Symbiosis Pharmaceutical Services Limited

Symbiosis is a world class Contract Manufacturing Organisation (CMO) based on the Stirling University Innovation Park. Specialising in the GMP manufacture and sterile fill-finish of vials for clinical trials and low volume commercial supply, Symbiosis is dedicated to the small scale manufacture of sterile pharmaceuticals for use in clinical trials.

Symbiosis Pharmaceutical Services Ltd

Symbiosis Pharmaceutical Services is a word class contract manufacturing organisation (CMO) specialising in the small-scale GMP manufacture of injectable pharmaceuticals for clinical trials. Established in 2011 in response to an increasing global demand for niche, sterile manufacturing specialists, the company created its purpose-built facility in Stirling, Scotland, specifically designed with biologic and small molecule production capabilities in mind.

Symbiosis supports biotech and pharmaceutical companies worldwide that require small-scale injectable products manufactured in short timeframes.

Manufacturing is performed in an FDA-approved and MHRA-licensed facility, which enables the team to fill bulk volumes, including products that require aseptic liquid filling and lyophilisation. Regulatory compliance, technical capability and operational flexibility are just some of  Symbiosis’ key strengths along with direct access to highly experienced people who deliver client drug development projects on time. 

With a current headcount of 102 and recent expansion, doubling its footprint, Symbiosis has a clearly defined growth strategy, which represents an exciting time to be part of this dynamic company.